Knollwood Investment Advisory’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$918K Hold
3,137
0.09% 173
2025
Q4
$1.1M Hold
3,137
0.1% 166
2025
Q3
$1.01M Sell
3,137
-27
-0.9% -$8.4K 0.09% 188
2025
Q2
$1.23M Hold
3,164
0.12% 167
2025
Q1
$1.38M Hold
3,164
0.15% 151
2024
Q4
$1.17M Hold
3,164
0.12% 171
2024
Q3
$1.65M Sell
3,164
-643
-17% -$344K 0.18% 138
2024
Q2
$2.06M Buy
3,807
+1,157
+44% +$612K 0.23% 105
2024
Q1
$1.37M Hold
2,650
0.25% 78
2023
Q4
$1.25M Buy
+2,650
New +$1.23M 0.26% 80

Other funds holding ELV

Knollwood Investment Advisory's ELV Position: Q1 2026 in Review

Knollwood Investment Advisory held its Elevance Health (ELV) position steady in Q1 2026 at 3,137 shares worth $918K. The position accounts for 0.09% of the portfolio, ranked #173.

Knollwood Investment Advisory first reported a position in ELV in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.06M in Q2 2024. 1,466 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Knollwood Investment Advisory held 3,137 shares of Elevance Health worth $918K as of Q1 2026.
  • Knollwood Investment Advisory left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.09% of Knollwood Investment Advisory's portfolio in Q1 2026, its #173 holding.
  • Knollwood Investment Advisory first reported a position in Elevance Health in Q4 2023 and has held it in 10 quarters since.
  • Knollwood Investment Advisory's Elevance Health position peaked at $2.06M in Q2 2024.
  • 1,466 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Knollwood Investment Advisory's 13F filing for Q1 2026, filed 14 May 2026.